SCHEMBL5828525

SCHEMBL5828525

O=C1C(Br)=C(c2c[nH]c3ccccc23)C(=O)N1COCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 3/20 0.59
SIRT1 Q96EB6 1/20 0.46
PRKACA P17612 4/20 0.43
PRKACG P22612 4/20 0.43
PRKACB P22694 4/20 0.43
PIM1 P11309 3/20 0.43
CCNB2 O95067 3/20 0.43
CDK1 P06493 3/20 0.43
CCNB1 P14635 3/20 0.43
CCNB3 Q8WWL7 3/20 0.43
CAMK2D Q13557 3/20 0.43
PRKCB P05771 2/20 0.43
PRKCA P17252 2/20 0.43
CDK4 P11802 2/20 0.43
CCND1 P24385 2/20 0.43
PRKD3 O94806 1/20 0.43
CCNE2 O96020 1/20 0.43
ABL1 P00519 1/20 0.43
PRKCG P05129 1/20 0.43
PRKCH P24723 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9374063 0.92 SIRT2 (0.70) SIRT2SIRT1PRKACAPRKACGPRKACB
SCHEMBL3971688 0.87 TRPM8 (0.46) SIRT2ALDH1A1MEN1MAPTKMT2A
SCHEMBL5828027 0.85 PIM1 (0.47) SIRT2PRKACAPIM1CDK1CAMK2D
SCHEMBL5828559 0.77 ALDH1A1 (0.49) GSK3BALDH1A1
SCHEMBL1395830 0.75 SIRT2 (0.55) SIRT2SIRT1PRKACAPRKACGPRKACB
SCHEMBL14560474 0.75 SIRT2 (0.56) SIRT2SIRT1PRKACAPRKACGPRKACB
SCHEMBL13169903 0.75 RPS6KB1 (0.51) SIRT2SIRT1PRKACAPRKACGPRKACB
SCHEMBL7193605 0.75 SIRT2 (1.00) SIRT2SIRT1PRKACAPRKACGPRKACB
SCHEMBL5827925 0.75 SIRT2 (0.48) SIRT2SIRT1PRKACAPRKACGPRKACB
SCHEMBL28101324 0.75 CAMK2D (0.48) SIRT2SIRT1PRKACAPRKACGPRKACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110218206-B Bisindolylmaleimide derivative and preparation method and application thereof 中国海洋大学 2022-03-04 CN disclosed
CN-110526903-B Bisindolylmaleimide derivative and preparation method and application thereof 中国海洋大学 2021-12-10 CN disclosed
CN-110526903-A Bisindole maleimide derivative and its preparation method and application OCEAN UNIV CHINA 2019-12-03 CN disclosed
CN-110218206-A Bisindole maleimide derivative and its preparation method and application 中国海洋大学 2019-09-10 CN disclosed
CN-106083830-B Bisindolylmaleimide derivative and preparation method and application thereof 中国海洋大学 2019-07-12 CN disclosed
CN-106146475-B Bisindolylmaleimide derivative and preparation method and application thereof 中国海洋大学 2019-05-17 CN disclosed
CN-106146475-A Bisindolylmaleimide derivative and preparation method and application thereof 中国海洋大学 2016-11-23 CN disclosed
CN-106083830-A Bisindolylmaleimide derivative and preparation method and application thereof 中国海洋大学 2016-11-09 CN disclosed
US-7001906-B2 Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives LES LABORATOIRES SERVIER (FR) 2006-02-21 US disclosed
US-20040152721-A1 Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives LES LABORATOIRES SERVIER (FR) 2004-08-05 US disclosed
EP-1409486-A1 PYRIDO-PYRIDO-PYRROLO PYRROLO-INDOLE AND PYRIDO-PYRROLO PYRROLO CARBAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES LES LABORATOIRES SERVIER (FR) 2004-04-21 EP disclosed
WO-2003002563-A1 PYRIDO-PYRIDO-PYRROLO PYRROLO-INDOLE AND PYRIDO-PYRROLO PYRROLO CARBAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES LES LABORATOIRES SERVIER (FR) 2003-01-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152721-A1 Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives PYM1, PNPO, IDO1 SIRT2 883/4885SIRT1 674/4885PRKACA 2590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.